Answers are grounded in this paper and cite their sources.
Review highlights systemic inflammatory indicators' impact on renal outcomes in IgA nephropathy, suggesting potential therapeutic approaches.
Numerous studies have shown that patients with IgA nephropathy (IgAN) exhibit a range of systemic inflammatory indicators that correlate with clinical outcomes. Elevated neutrophil-to-lymphocyte ratios and systemic immune inflammation index scores have been associated with poorer renal survival and strengthened risk of progression to end-stage renal disease (ESRD). The relationship between systemic inflammation and IgAN progression provides valuable insights into potential therapeutic strategies and prognostic implications for cases suffering from this disease. However, this tool has some limitations which should be respected following its application.
No takes yet. Share an insight, caveat, or question.
Mojtahedi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: